• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于LASSO的风险预测模型,用于接受综合唾液腺保留螺旋断层放疗技术治疗的鼻咽癌患者放射性口干症的预测

A Risk Prediction Model by LASSO for Radiation-Induced Xerostomia in Patients With Nasopharyngeal Carcinoma Treated With Comprehensive Salivary Gland-Sparing Helical Tomotherapy Technique.

作者信息

Teng Feng, Fan Wenjun, Luo Yanrong, Xu Shouping, Gong Hanshun, Ge Ruigang, Zhang Xinxin, Wang Xiaoning, Ma Lin

机构信息

Department of Radiation Oncology, China-Japan Friendship Hospital, Beijing, China.

Department of Radiation Oncology, Medical School of the Chinese People's Liberation Army (PLA), Beijing, China.

出版信息

Front Oncol. 2021 Feb 26;11:633556. doi: 10.3389/fonc.2021.633556. eCollection 2021.

DOI:10.3389/fonc.2021.633556
PMID:33718219
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7953987/
Abstract

OBJECTIVE

This study aimed to develop a least absolute shrinkage and selection operator (LASSO)-based multivariable normal tissue complication probability (NTCP) model to predict radiation-induced xerostomia in patients with nasopharyngeal carcinoma (NPC) treated with comprehensive salivary gland-sparing helical tomotherapy technique.

METHODS AND MATERIALS

LASSO with the extended bootstrapping technique was used to build multivariable NTCP models to predict factors of patient-reported xerostomia relieved by 50% and 80% compared with the level at the end of radiation therapy within 1 year and 2 years, R50-1year and R80-2years, in 203 patients with NPC. The model assessment was based on 10-fold cross-validation and the area under the receiver operating characteristic curve (AUC).

RESULTS

The prediction model by LASSO with 10-fold cross-validation showed that radiation-induced xerostomia recovery could be predicted by prognostic factors of R50-1year (age, gender, T stage, UICC/AJCC stage, parotid Dmean, oral cavity Dmean, and treatment options) and R80-2years (age, gender, T stage, UICC/AJCC stage, oral cavity Dmean, N stage, and treatment options). These prediction models also demonstrated a good performance by the AUC.

CONCLUSION

The prediction models of R50-1year and R80-2years by LASSO with 10-fold cross-validation were recommended to validate the NTCP model before comprehensive salivary gland-sparing radiation therapy in patients with NPC.

摘要

目的

本研究旨在开发一种基于最小绝对收缩与选择算子(LASSO)的多变量正常组织并发症概率(NTCP)模型,以预测采用保留唾液腺的螺旋断层放射治疗技术治疗的鼻咽癌(NPC)患者放射性口干的发生情况。

方法与材料

采用带有扩展自抽样技术的LASSO构建多变量NTCP模型,以预测203例NPC患者在放疗结束后1年内和2年内,患者报告的口干缓解50%和80%的相关因素,即R50 - 1年和R80 - 2年。模型评估基于10折交叉验证和受试者操作特征曲线下面积(AUC)。

结果

采用10折交叉验证的LASSO预测模型显示,R50 - 1年(年龄、性别、T分期、UICC/AJCC分期、腮腺平均剂量、口腔平均剂量和治疗方案)和R80 - 2年(年龄、性别、T分期、UICC/AJCC分期、口腔平均剂量、N分期和治疗方案)的预后因素可预测放射性口干的恢复情况。这些预测模型的AUC也显示出良好的性能。

结论

建议采用10折交叉验证的LASSO建立的R50 - 1年和R80 - 2年预测模型,在NPC患者进行保留唾液腺的全面放射治疗前对NTCP模型进行验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9de9/7953987/e85521d51019/fonc-11-633556-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9de9/7953987/29f43de82bc4/fonc-11-633556-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9de9/7953987/51451a5d92b5/fonc-11-633556-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9de9/7953987/e85521d51019/fonc-11-633556-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9de9/7953987/29f43de82bc4/fonc-11-633556-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9de9/7953987/51451a5d92b5/fonc-11-633556-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9de9/7953987/e85521d51019/fonc-11-633556-g003.jpg

相似文献

1
A Risk Prediction Model by LASSO for Radiation-Induced Xerostomia in Patients With Nasopharyngeal Carcinoma Treated With Comprehensive Salivary Gland-Sparing Helical Tomotherapy Technique.一种基于LASSO的风险预测模型,用于接受综合唾液腺保留螺旋断层放疗技术治疗的鼻咽癌患者放射性口干症的预测
Front Oncol. 2021 Feb 26;11:633556. doi: 10.3389/fonc.2021.633556. eCollection 2021.
2
Patient- and therapy-related factors associated with the incidence of xerostomia in nasopharyngeal carcinoma patients receiving parotid-sparing helical tomotherapy.接受保留腮腺螺旋断层放疗的鼻咽癌患者中与口干症发生率相关的患者及治疗相关因素。
Sci Rep. 2015 Aug 20;5:13165. doi: 10.1038/srep13165.
3
Using multivariate regression model with least absolute shrinkage and selection operator (LASSO) to predict the incidence of Xerostomia after intensity-modulated radiotherapy for head and neck cancer.使用带有最小绝对收缩和选择算子(LASSO)的多元回归模型来预测头颈部癌调强放疗后口干症的发生率。
PLoS One. 2014 Feb 28;9(2):e89700. doi: 10.1371/journal.pone.0089700. eCollection 2014.
4
LASSO NTCP predictors for the incidence of xerostomia in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.用于预测头颈部鳞状细胞癌和鼻咽癌患者口干症发生率的LASSO正常组织并发症概率预测因子。
Sci Rep. 2014 Aug 28;4:6217. doi: 10.1038/srep06217.
5
Development and validation of a nomogram for prediction of recovery from moderate-severe xerostomia post-radiotherapy in nasopharyngeal carcinoma patients.制定和验证预测鼻咽癌患者放疗后中重度口干恢复的列线图。
Radiother Oncol. 2023 Jul;184:109683. doi: 10.1016/j.radonc.2023.109683. Epub 2023 Apr 28.
6
Statistical validation of normal tissue complication probability models.正常组织并发症概率模型的统计学验证。
Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):e123-9. doi: 10.1016/j.ijrobp.2012.02.022. Epub 2012 Apr 27.
7
Reducing Xerostomia by Comprehensive Protection of Salivary Glands in Intensity-Modulated Radiation Therapy with Helical Tomotherapy Technique for Head-and-Neck Cancer Patients: A Prospective Observational Study.运用螺旋断层放疗技术的调强放疗对头颈部癌症患者进行唾液腺全面保护以减少口干症:一项前瞻性观察研究。
Biomed Res Int. 2019 Jul 14;2019:2401743. doi: 10.1155/2019/2401743. eCollection 2019.
8
Three-Dimensional Deep Learning Normal Tissue Complication Probability Model to Predict Late Xerostomia in Patients With Head and Neck Cancer.用于预测头颈癌患者晚期口干症的三维深度学习正常组织并发症概率模型
Int J Radiat Oncol Biol Phys. 2025 Jan 1;121(1):269-280. doi: 10.1016/j.ijrobp.2024.07.2334. Epub 2024 Aug 13.
9
Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma.鼻咽癌根治性放疗后获得性鼻腔狭窄和闭锁的正常组织并发症概率模型的建立与验证
Radiother Oncol. 2021 Jul;160:9-17. doi: 10.1016/j.radonc.2021.03.040. Epub 2021 Apr 9.
10
Modelling Radiation-Induced Salivary Dysfunction during IMRT and Chemotherapy for Nasopharyngeal Cancer Patients.鼻咽癌患者调强放疗和化疗期间放射性唾液腺功能障碍的建模
Cancers (Basel). 2021 Aug 6;13(16):3983. doi: 10.3390/cancers13163983.

引用本文的文献

1
Cohort-based nomogram for forensic prediction of SCD: a single-center pilot study.基于队列的心脏性猝死法医预测列线图:一项单中心试点研究。
Forensic Sci Med Pathol. 2025 Jan 11. doi: 10.1007/s12024-024-00920-6.
2
Determining risk and predictors of head and neck cancer treatment-related lymphedema: A clinicopathologic and dosimetric data mining approach using interpretable machine learning and ensemble feature selection.确定头颈癌治疗相关淋巴水肿的风险及预测因素:一种使用可解释机器学习和集成特征选择的临床病理及剂量学数据挖掘方法。
Clin Transl Radiat Oncol. 2024 Feb 28;46:100747. doi: 10.1016/j.ctro.2024.100747. eCollection 2024 May.
3

本文引用的文献

1
Modeling of Xerostomia After Radiotherapy for Head and Neck Cancer: A Registry Study.头颈部癌放疗后口干症的建模:一项登记研究。
Front Oncol. 2020 Aug 14;10:1647. doi: 10.3389/fonc.2020.01647. eCollection 2020.
2
Reducing Xerostomia by Comprehensive Protection of Salivary Glands in Intensity-Modulated Radiation Therapy with Helical Tomotherapy Technique for Head-and-Neck Cancer Patients: A Prospective Observational Study.运用螺旋断层放疗技术的调强放疗对头颈部癌症患者进行唾液腺全面保护以减少口干症:一项前瞻性观察研究。
Biomed Res Int. 2019 Jul 14;2019:2401743. doi: 10.1155/2019/2401743. eCollection 2019.
3
Future of Radiotherapy in Nasopharyngeal Carcinoma.
Fine Motor Skill Decline After Brain Radiation Therapy-A Multivariate Normal Tissue Complication Probability Study of a Prospective Trial.
脑放射治疗后精细运动技能下降-一项前瞻性试验的多变量正常组织并发症概率研究。
Int J Radiat Oncol Biol Phys. 2023 Nov 1;117(3):581-593. doi: 10.1016/j.ijrobp.2023.04.033. Epub 2023 May 6.
4
Radiotherapy for head and neck tumours using an oral fixation and parameter acquisition device and TOMO technology: a randomised controlled study.头颈部肿瘤的放疗:采用口腔固定和参数采集装置及螺旋断层放疗技术:一项随机对照研究。
BMJ Open. 2021 Nov 12;11(11):e052542. doi: 10.1136/bmjopen-2021-052542.
5
A nomogram for predicting late radiation-induced xerostomia among locoregionally advanced nasopharyngeal carcinoma in intensity modulated radiation therapy era.调强放疗时代局部晚期鼻咽癌患者放射性口干预测列线图的建立。
Aging (Albany NY). 2021 Jul 19;13(14):18645-18657. doi: 10.18632/aging.203308.
鼻咽癌放射治疗的未来。
Br J Radiol. 2019 Oct;92(1102):20190209. doi: 10.1259/bjr.20190209. Epub 2019 Jul 9.
4
A model for predicting the dose to the parotid glands based on their relative overlapping with planning target volumes during helical radiotherapy.基于腮腺与螺旋调强放疗计划靶区的相对重叠度来预测腮腺剂量的模型。
J Appl Clin Med Phys. 2018 Mar;19(2):48-53. doi: 10.1002/acm2.12203. Epub 2017 Nov 6.
5
Parotid gland mean dose as a xerostomia predictor in low-dose domains.腮腺平均剂量作为低剂量域口干症预测指标
Acta Oncol. 2017 Sep;56(9):1197-1203. doi: 10.1080/0284186X.2017.1324209. Epub 2017 May 13.
6
Patient- and therapy-related factors associated with the incidence of xerostomia in nasopharyngeal carcinoma patients receiving parotid-sparing helical tomotherapy.接受保留腮腺螺旋断层放疗的鼻咽癌患者中与口干症发生率相关的患者及治疗相关因素。
Sci Rep. 2015 Aug 20;5:13165. doi: 10.1038/srep13165.
7
Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia.头颈部癌适应性放疗对保留腮腺及降低口干风险的影响。
Radiat Oncol. 2015 Jan 9;10:6. doi: 10.1186/s13014-014-0318-z.
8
LASSO NTCP predictors for the incidence of xerostomia in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.用于预测头颈部鳞状细胞癌和鼻咽癌患者口干症发生率的LASSO正常组织并发症概率预测因子。
Sci Rep. 2014 Aug 28;4:6217. doi: 10.1038/srep06217.
9
Using multivariate regression model with least absolute shrinkage and selection operator (LASSO) to predict the incidence of Xerostomia after intensity-modulated radiotherapy for head and neck cancer.使用带有最小绝对收缩和选择算子(LASSO)的多元回归模型来预测头颈部癌调强放疗后口干症的发生率。
PLoS One. 2014 Feb 28;9(2):e89700. doi: 10.1371/journal.pone.0089700. eCollection 2014.
10
Xerostomia after radiotherapy. What matters--mean total dose or dose to each parotid gland?放疗后口干症。什么更重要——平均总剂量还是每个腮腺的剂量?
Strahlenther Onkol. 2013 Mar;189(3):216-22. doi: 10.1007/s00066-012-0257-2. Epub 2013 Jan 27.